About AvantStay
AvantStay is a private company based in Culver City, California. It has reported $176,050,108 raised in two offerings on Form D since March 2022. Its chief executive is Sean Breuner.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 3, 2025 | Jul 13, 2026 | $50,859,879of $50.8M target | 43 | $1.1M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 23, 2021 | Mar 4, 2022 | $125,190,229of $129.1M target | 23 | $5.4M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $176,050,108 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on AvantStay's Form D filed Jul 13, 2026.
SC
BY
SB
RD
EW
Eric Wiesen
Director
RR
Rishi Reddy
Director
Also a co-founder & executive chairman at ChronicleBio, a director at ClinTrial Research and an executive officer and director at Fathom.
FT
Frederick Tuomi
Director
JS
Earlier filings also listed Jodi Kessler (director, last listed Mar 2022).